Log in

Relevant bibliographies by topics / Selective thrombolysis / Journal articles

To see the other types of publications on this topic, follow the link: Selective thrombolysis.

Journal articles on the topic 'Selective thrombolysis'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Selective thrombolysis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Earnshaw, J. J., and P. Birch. "Peripheral Thrombolysis: State of the Art." Cardiovascular Surgery 3, no. 4 (1995): 357–67. http://dx.doi.org/10.1177/096721099500300402.

Full text

Abstract:

Peripheral thrombolysis has become established in the last decade as an alternative method of treatment for acute limb ischaemia. New techniques of accelerated thrombolysis have expanded the indications to include almost all affected patients. Attention to detail and avoidance of known pitfalls, together with close cooperation between vascular surgeon and radiologist, ensure optimum results with minimum complications. A modern integrated lysis programme may vary from initial thrombolytic treatment for all patients with acute limb ischaemia to a selective policy of surgery and thrombolysis depe

APA, Harvard, Vancouver, ISO, and other styles

2

Igor, B. Kovalenko* Zhanna Yu. Chefranova Nadezhda S. Zueva Vyacheslav D. Polyansky. "APPLICATION OF SELECTIVE THROMBOLYTIC THERAPY FOR ISCHEMIC STROKE TREATMENT." Indo American Journal of Pharmaceutical Sciences 04, no. 10 (2017): 3727–31. https://doi.org/10.5281/zenodo.1019479.

Full text

Abstract:

The article deals with the review and analysis of the major study related to both applications of STLT and that compared to systemic thrombolysis which demonstrate good functional results after 90 days of STLT application and less number of intracranial hemorrhage during 24 hours. The comparative analysis of the outcomes of ischemic stroke treatment based on systemic and selective thrombolysis by Actilyse was conducted in Belgorod Regional Clinical Hospital. The procedure of selective thrombolysis was described. The analysis of the effectiveness and complications depending on medication dose a

APA, Harvard, Vancouver, ISO, and other styles

3

Park, Jae Hyung, Kil Sun Park, Jin Wook Chung, Joon Koo Han, Dae Young Kim, and Sang Joon Kim. "Selective arterial thrombolysis with urokinase." Journal of the Korean Radiological Society 27, no. 4 (1991): 441. http://dx.doi.org/10.3348/jkrs.1991.27.4.441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Yu, Boram Gu, Isabelle I. Salles-Crawley, et al. "Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy." Science Advances 7, no. 23 (2021): eabf9033. http://dx.doi.org/10.1126/sciadv.abf9033.

Full text

Abstract:

Clinical use of tissue plasminogen activator (tPA) in thrombolytic therapy is limited by its short circulation time and hemorrhagic side effects. Inspired by fibrinogen binding to activated platelets, we report a fibrinogen-mimicking, multiarm nanovesicle for thrombus-specific tPA delivery and targeted thrombolysis. This biomimetic system is based on the lipid nanovesicle coated with polyethylene glycol (PEG) terminally conjugated with a cyclic RGD (cRGD) peptide. Our experiments with human blood demonstrated its highly selective binding to activated platelets and efficient tPA release at a th

APA, Harvard, Vancouver, ISO, and other styles

5

Duraes, Andre R., and Jose C. Brito. "Selective Intraarterial Thrombolysis for Cardioembolic Stroke." New England Journal of Medicine 367, no. 17 (2012): e24. http://dx.doi.org/10.1056/nejmicm1211164.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Witt, W., B. Baldus, P. Bringmann, L. Cashion, P. Donner, and WD Schleuning. "Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats." Blood 79, no. 5 (1992): 1213–17. http://dx.doi.org/10.1182/blood.v79.5.1213.1213.

Full text

Abstract:

Abstract rDSPA alpha 1 (recombinant Desmodus salivary plasminogen activator alpha 1) is a recombinant protein corresponding to a natural plasminogen activator from the vampire bat Desmodus rotundus. The thrombolytic properties of rDSPA alpha 1 and tissue-type plasminogen activator (t-PA) were compared in a rat model of pulmonary embolism. Whole blood clots, produced in vitro and labeled with 125I-fibrinogen, were embolized into the lungs of anesthetized rats. Thrombolysis was calculated from the difference between initial clot radioactivity and that remaining in the lungs at 60 minutes. Blood

APA, Harvard, Vancouver, ISO, and other styles

7

Witt, W., B. Baldus, P. Bringmann, L. Cashion, P. Donner, and WD Schleuning. "Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats." Blood 79, no. 5 (1992): 1213–17. http://dx.doi.org/10.1182/blood.v79.5.1213.bloodjournal7951213.

Full text

Abstract:

rDSPA alpha 1 (recombinant Desmodus salivary plasminogen activator alpha 1) is a recombinant protein corresponding to a natural plasminogen activator from the vampire bat Desmodus rotundus. The thrombolytic properties of rDSPA alpha 1 and tissue-type plasminogen activator (t-PA) were compared in a rat model of pulmonary embolism. Whole blood clots, produced in vitro and labeled with 125I-fibrinogen, were embolized into the lungs of anesthetized rats. Thrombolysis was calculated from the difference between initial clot radioactivity and that remaining in the lungs at 60 minutes. Blood was sampl

APA, Harvard, Vancouver, ISO, and other styles

8

Pyatikop, V. O., Yu O. Kotlyarevsky, and Yu G. Sergienko. "Our experience in using of intravascular recanalization methods for treatment of acute ischemic stroke." Endovascular Neuroradiology 32, no. 2 (2020): 67–78. http://dx.doi.org/10.26683/2304-9359-2020-2(32)-67-78.

Full text

Abstract:

Objective ‒ to evaluate results of the introduction of intravascular recanalization in the provision of emergency care to patients with ischemic stroke.Materials and methods. The experience of intraarterial thrombolysis on the example of 25 clinical cases was analysed. In 22 patients was performed selective intra-arterial thrombolysis, in 3 cases ‒ with thrombaspiration. All patients had a severe stroke, ranging from 15 to 25 points NIHSS. Confirmation of the diagnosis was performed according to computed tomography scan), ultrasound of the precerebral and cerebral arteries. Selective cerebral

APA, Harvard, Vancouver, ISO, and other styles

9

Dong, Ningzheng, Valdeci Da Cunha, Andrej Citkowicz та ін. "P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator α1". Thrombosis and Haemostasis 92, № 11 (2004): 956–65. http://dx.doi.org/10.1160/th04-03-0177.

Full text

Abstract:

SummaryDuring thrombosis, P-selectin is expressed on the surface of activated endothelial cells and platelets. We hypothesized that targeting a plasminogen activator (PA) to P-selectin would enhance local thrombolysis and reduce bleeding risk. Previously, a urokinase (uPA)/anti-P-selectin antibody (HuSZ51) fusion protein was shown to increase fibrinolysis in a hamster pulmonary embolism model. To explore the therapeutic potential of this targeting strategy, we fused the fibrin-selective Desmodus rotundus salivary PA α1 (dsPAα1) to HuSZ51 and compared the fibrinolytic activity of P-selectin-tar

APA, Harvard, Vancouver, ISO, and other styles

10

Loscalzo, J., T. P. Wharton, J. M. Kirshenbaum, et al. "Clot-selective coronary thrombolysis with pro-urokinase." Circulation 79, no. 4 (1989): 776–82. http://dx.doi.org/10.1161/01.cir.79.4.776.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Nikolskiy, A. V., V. N. Kravchuk, A. S. Mukhin, et al. "Results of treatment of acute arterial thrombosis in patients with severe course of coronavirus infection COVID-19." Hirurg (Surgeon), no. 5 (October 22, 2022): 17–27. http://dx.doi.org/10.33920/med-15-2205-03.

Full text

Abstract:

Acute arterial thrombosis against the background of the novel coronavirus infection COVID-19 is an unfavorable complication. The survival prognosis in this category of patients is much worse than in the rest of the patient population. The aim of the work is to compare the immediate results of various methods of treating acute arterial insufficiency in patients with the novel coronavirus infection COVID-19, complicated by the development of acute arterial thrombosis of various localizations. 42 clinical cases of treatment of acute arterial pathology in patients with confirmed COVID-19 infection

APA, Harvard, Vancouver, ISO, and other styles

12

Ikramov, A. I., and N. G. Dadamyants. "Efficacy of Thrombolytic Therapy in Treatment of Patients with Ischemic Stroke." Medical Visualization, no. 1 (February 28, 2017): 57–62. http://dx.doi.org/10.24835/1607-0763-2017-1-57-62.

Full text

Abstract:

The purpose: to evaluate the effectiveness of thrombolytic therapy in patients with ischemic stroke according to radiological methods.Materials and methods. The study included 60 people who were divided into two groups. The main group included 34 (56.7%) patients with ischemic stroke (20 men and 14 women) aged 22 to 78 years (mean age 62 ± 8.6 years) who were treated in Republican research center of emergency medical care. The control group consisted of 26 (43.3%) patients to estimate the parameters of normeperidine in the middle cerebral artery (MCA): the maximum blood flow velocity, linear b

APA, Harvard, Vancouver, ISO, and other styles

13

Schellen, Christoph, Julia Ferrari, Wilfried Lang, and Marek Sykora. "Effects of SSRI exposure on hemorrhagic complications and outcome following thrombolysis in ischemic stroke." International Journal of Stroke 13, no. 5 (2017): 511–17. http://dx.doi.org/10.1177/1747493017743055.

Full text

Abstract:

Background Selective serotonin reuptake inhibitors (SSRI) may interfere with platelet function, and pre-stroke SSRI treatment has been associated with increased hematoma volumes and mortality in hemorrhagic stroke patients. The effects of SSRI on the risk of hemorrhagic complications after thrombolysis in ischemic stroke patients are unclear. Aims To examine the effects of pre-stroke SSRI exposure on bleeding complications, functional outcome, and mortality following thrombolysis in ischemic stroke. Methods Data including standard demographic and clinical variables as well as baseline and foll

APA, Harvard, Vancouver, ISO, and other styles

14

Picard, L., S. Bracard, L. Maffei, et al. "Selective Intra-Arterial Thrombolysis for Embolic Complications of Cerebral Endovascular Therapy." Interventional Neuroradiology 2, no. 4 (1996): 263–69. http://dx.doi.org/10.1177/159101999600200403.

Full text

Abstract:

Cerebral thrombo-embolic complications seldom occur during intracranial endovascular therapeutic procedures. Yet, despite a systemic preventive regimen of pre-operative intravenous acetylsalicylic acid and effective systemic heparinisation, we encountered seven complications of this type over a period of five years, a 3.7‰ incidence (7/1858). Local intra-arterial thrombolysis performed immediately after the thrombo-embolic complication resulted in complete recanalization in five cases and partial recanalization in two. CT scans performed 24 hours after thrombolysis were normal in six of the se

APA, Harvard, Vancouver, ISO, and other styles

15

Kalinin, R. E., E. A. Klimentova, A. S. Pshennikov, A. A. Egorov, and I. A. Suchkov. "Selective intra-arterial thrombolysis in acute limb ischemia." Angiology and Vascular Surgery 30, no. 1 (2024): 7–17. http://dx.doi.org/10.33029/1027-6661-2024-30-1-7-17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Parkhomenko, S. I., K. B. Lapshin, T. D. Glebovskaya, et al. "Pulmonary embolism: options for interventional treatment in the intermediate-high risk group." "Arterial’naya Gipertenziya" ("Arterial Hypertension") 29, no. 3 (2023): 306–19. http://dx.doi.org/10.18705/1607-419x-2023-29-3-306-319.

Full text

Abstract:

Selective transcatheter thrombolysis (STT) in patients with pulmonary embolism (PE) with an intermediatehigh risk of 30-day mortality is an option for rapid lung reperfusion with a decrease in right ventricular (RV) afterload, which largely determines the prognosis of patients.Objective. Comparison of the efficacy of STT using reduced doses of alteplase and routine conservative treatment of patients with PE with an intermediate-high risk of 30-day mortality using a retrospective analysis of the data from Almazov National Medical Research Centre.Design and methods. The retrospective single-cent

APA, Harvard, Vancouver, ISO, and other styles

17

Vasilchuk, L. F., N. N. Ioskevich, V. A. Chernii, S. P. Antonenko, and S. I. Kotov. "SELECTIVE THROMBOLYSIS IN ACUTE INTERNAL CAROTID ARTERY BASIN TROMBOSIS." Journal of the Grodno State Medical University 16, no. 3 (2018): 329–32. http://dx.doi.org/10.25298/2221-8785-2018-16-3-329-332.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Stief, Thomas W. "Nonradical excited oxygen species induce selective thrombolysis in vivo." Thrombosis Research 62, no. 3 (1991): 147–63. http://dx.doi.org/10.1016/0049-3848(91)90189-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

da Cunha, Valdeci, Jon Vincelette, Lei Zhao, et al. "A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) – Part II: Enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis." Thrombosis and Haemostasis 97, no. 01 (2007): 54–61. http://dx.doi.org/10.1160/th06-09-0552.

Full text

Abstract:

SummaryWe have discovered a novel small-molecule TAFIa inhibitor, BX 528, which is potent, highly selective against other carboxypeptidases and safe. The present study was to determine if BX 528 can enhance exogenous and endogenous thrombolysis in four different animal models. In the first three models, a thrombus was induced by FeCl2 (dogs) or laser (rats) injury of the femoral artery, or formed ex vivo and implanted in the jugular vein in rabbits. A low dose of exogenous t-PA was given to induce a lowlevel thrombolysis on an established thrombus. Co-treatment with BX 528 further enhanced the

APA, Harvard, Vancouver, ISO, and other styles

20

Perkins, W. R., D. E. Vaughan, S. R. Plavin, et al. "Streptokinase Entrapment in Interdigitation-Fusion Liposomes Improves Thrombolysis in an Experimental Rabbit Model." Thrombosis and Haemostasis 77, no. 06 (1997): 1174–78. http://dx.doi.org/10.1055/s-0038-1656133.

Full text

Abstract:

SummaryThe successful design of new thrombolytic agents depends on providing these agents with increased clot selectivity. As recently demonstrated (10), entrapment of tissue plasminogen activator into liposomes apparently provided the selective targeting needed to improve the efficacy of this fibrinolytic agent. To test whether liposomal entrapment would benefit streptokinase, a fibrinolytic agent with a different mode of action and inactivation, we compared liposomal streptokinase with free streptokinase in an experimental rabbit model of thrombolysis.First we adapted a new method to produce

APA, Harvard, Vancouver, ISO, and other styles

21

Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al. "Thrombolysis with an Escherichia coli-Produced Recombinant Plasminogen Activator (BM 06.022) in the Rabbit Model of Jugular Vein Thrombosis." Thrombosis and Haemostasis 65, no. 05 (1991): 560–64. http://dx.doi.org/10.1055/s-0038-1648190.

Full text

Abstract:

SummaryThe recombinant plasminogen activator BM 06.022 consists of the kringle 2 and the protease domains of human t-PA and is unglycosylated because of the expression in Escherichia coli The thrombolytic and pharmacokinetic properties as well as the hemostasis effects of BM 06.022 were investigated in the rabbit model of jugular vein thrombosis. The thrombi were 125I-fibrin labeled. Intravenous bolus injection of 50, 100, 200, and 400 kU/ kg BM 06.022 or 400, 800, and 1600 kU/kg alteplase over 15 s to six rabbits/dose produced a dose-dependent increase of thrombolysis determined 2 h post inje

APA, Harvard, Vancouver, ISO, and other styles

22

MIZUTANI, Masahiro, Takeshi KOBAYASHI, Masaaki MAKITA, et al. "Potential thrombolysis under selective infusion of autologous plasmin(AP) solution." Japanese Heart Journal 30, no. 5 (1989): 723–32. http://dx.doi.org/10.1536/ihj.30.723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

SLANY, J., B. ZIEGLER, P. ZAJICEK, and R. KARNIK. "Selective intracoronary thrombolysis in the coronary care unit without cineangiography." European Heart Journal 6, no. 2 (1985): 105–8. http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a061822.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Tsekov, Christo, Anelia Loukova, and Valeri Gelev. "Successful selective arterial thrombolysis in patient with acute abdominal thromboembolism." Turkish Journal of Emergency Medicine 16, no. 2 (2016): 86–88. http://dx.doi.org/10.1016/j.tjem.2015.03.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Lupattelli, Luciano, Francesco Barzi, Paolo Corneli, Angelo Lemmi, and Stefano Mosca. "Selective thrombolysis with low-dose urokinase in chronic arteriosclerotic obstructions." Cardiovascular and Interventional Radiology 11, no. 3 (1988): 123–26. http://dx.doi.org/10.1007/bf02577100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lee, Watson, Mammen, Phillips-Hughes, and Morris. "Successful selective thrombolysis of a spontaneous transplant renal vein thrombosis." BJU International 83, no. 7 (2001): 869–70. http://dx.doi.org/10.1046/j.1464-410x.1999.00105.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Hai, Feng, Chen Xueming, Zhang Zhiwen, et al. "Acute Massive Pulmonary Thromboembolism Treated by Selective Catheter-Directed Thrombolysis." Annals of Vascular Surgery 50 (July 2018): 8–14. http://dx.doi.org/10.1016/j.avsg.2017.11.040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Aldağ, Mustafa, and Ufuk Çiloğlu. "Combined pharmacomechanical thrombectomy with selective catheter-directed thrombolysis in patients with acute proximal deep vein thrombosis." Turkish Journal of Thoracic and Cardiovascular Surgery 30, no. 2 (2022): 176–83. http://dx.doi.org/10.5606/tgkdc.dergisi.2022.22736.

Full text

Abstract:

Background: The aim of this study was to evaluate the characteristics and the outcomes of combined percutaneous pharmacomechanical thrombectomy with selective catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Methods: Between March 2018 and February 2020, a total of 37 patients (21 males, 16 females; mean age: 55±13.8 years; range, 21 to 79 years) with symptomatic acute iliofemoral vein thrombosis who underwent combined percutaneous pharmacomechanical thrombectomy and catheter-directed thrombolysis were retrospectively analyzed. All patients received a three-step thera

APA, Harvard, Vancouver, ISO, and other styles

29

Adachi, Hidemitsu, Yohei Mineharu, Tatsuya Ishikawa, et al. "Stenting for acute cerebral venous sinus thrombosis in the superior sagittal sinus." Interventional Neuroradiology 21, no. 6 (2015): 719–23. http://dx.doi.org/10.1177/1591019915609120.

Full text

Abstract:

Endovascular treatment for superior sagittal sinus (SSS) thrombosis is not always successful because of difficult access and long thrombus lesions. We report the first two cases of patients with acute cerebral venous sinus thrombosis at the SSS that was not recanalized by anticoagulation, mechanical thrombectomy, or thrombolysis, but was successfully treated by stent placement. Case 1 was a 37-year-old woman with bilateral subdural hematomas. Digital subtraction angiography showed obstruction of the sinus from the SSS to the right transverse sinus. Recanalization was achieved by selective thro

APA, Harvard, Vancouver, ISO, and other styles

30

Alekseeva, Yu M., V. I. Potievskaya, D. P. Lebedev, and E. V. Agagulyan. "CASE OF SUCCESSFUL TREATMENT OF PULMONARY EMBOLISM WITH INVASIVE METHODS." Journal of Clinical Practice 1, no. 4 (2010): 22–25. http://dx.doi.org/10.17816/clinpract1422-25.

Full text

Abstract:

This research is devoted to analyzing of the case of pulmonary embolism in a young woman with deep vein thrombosis taking oral contraceptives and successfully treated by surgical methods. Pulmonary angiography performed in patient L. allowed to confirm the diagnosis ofpulmonary embolism and reveal the localization of the thrombus. The treatment included selective thrombolysis by actilyse through catheter in the pulmonary artery. The treatment was not only non-invasive but included surgical intervention. Using of invasive methods, thrombolysis and anticoagulant medication allowed to stabilize t

APA, Harvard, Vancouver, ISO, and other styles

31

FUJIWARA, HISAYOSHI, TOMOYA ONODERA, MASARU TANAKA, et al. "Macroscopic hemorrhagic infarction following selective coronary thrombolysis in acute myocardial infarction." Japanese Circulation Journal 49, no. 6 (1985): 649–52. http://dx.doi.org/10.1253/jcj.49.649.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Hurst, Robert W., Eric C. Raps, Eric Zager, Steven L. Galetta, and E. S. Flamm. "Selective intra-arterial thrombolysis in acute stroke: Implications for emergency management." Journal of Stroke and Cerebrovascular Diseases 4, no. 1 (1994): 30–35. http://dx.doi.org/10.1016/s1052-3057(10)80143-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ko, Sang Jun, In Choel Shin, Dae Won Kim, Si Sung Choi, and Yun Sik Yang. "Safety and Efficacy of Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion." Korean Journal of Ophthalmology 35, no. 4 (2021): 261–71. http://dx.doi.org/10.3341/kjo.2020.0082.

Full text

Abstract:

Purpose: The purpose of this study was to determine the efficacy and safety of selective intra-arterial thrombolysis in patients with central retinal artery occlusion (CRAO).Methods: Medical records for 44 eyes of 44 patients diagnosed with acute non-arteritic CRAO and thrombolysis between October 2010 and February 2019 were analyzed retrospectively. Based on visual acuity, fundoscopic findings, and fluorescein angiography, the patients were classified into three stages: incomplete, subtotal, and total. The perfusion state using the best-corrected visual acuity (BCVA), arm to retina time, and

APA, Harvard, Vancouver, ISO, and other styles

34

Hashimoto, Masaru, Tsutomu Yamashita, Kazuhiro Oiwa, Sadahiro Watanabe, John Giddings, and Junichiro Yamamoto. "Enhancement of Endogenous Plasminogen Activator-induced Thrombolysis by Argatroban and APC and Its Control by TAFI, Measured in An Arterial Thrombolysis Model In Vivo Using Rat Mesenteric Arterioles." Thrombosis and Haemostasis 87, no. 01 (2002): 110–13. http://dx.doi.org/10.1055/s-0037-1612952.

Full text

Abstract:

SummaryRecent in vitro studies have demonstrated that thrombin inhibits fibrinolysis through thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B). We have recently shown that endogenous fibrinolysis in vivo is enhanced by activated protein C (APC) and the selective thrombin inhibitor, argatroban. The aim of the present study was to examine the role of TAFI in these fibrinolytic mechanisms in vivo using purified porcine pancreatic carboxypeptidase B (PPCPB) and a specific TAFIa inhibitor, potato tuber carboxypeptidase B inhibitor (PTCI) in a newly established arteria

APA, Harvard, Vancouver, ISO, and other styles

35

Tsuda, Masashi, Mamoru Nakamura, Yasuo Yamada, Haruo Saito, Tadashi Ishibashi, and Shoki Takahashi. "Acute Superior Mesenteric Artery Embolism: Rapid Reperfusion with Hydrodynamic Thrombectomy and Pharmacological Thrombolysis." Journal of Endovascular Therapy 10, no. 5 (2003): 1015–18. http://dx.doi.org/10.1177/152660280301000527.

Full text

Abstract:

Purpose: To report a case of acute superior mesenteric artery (SMA) embolism successfully treated with hydrodynamic thrombectomy and pharmacological thrombolysis. Case Report: A 67-year-old man was admitted to the hospital with acute severe abdominal pain. Selective angiography via a femoral puncture revealed a complete embolic occlusion distal to the first jejunal branch of the SMA. Hydrodynamic thrombectomy resolved the severe abdominal pain of the patient in approximately 10 minutes after the start of thrombectomy. Local continuous thrombolysis with urokinase resulted in near complete resto

APA, Harvard, Vancouver, ISO, and other styles

36

Derksen, Wouter J. M., Iris E. M. de Jong, Carlijn I. Buis, et al. "Successful Thrombectomy via a Surgically Reopened Umbilical Vein for Extended Portal Vein Thrombosis Caused by Portal Vein Embolization prior to Extended Liver Resection." Case Reports in Gastroenterology 14, no. 2 (2020): 320–28. http://dx.doi.org/10.1159/000508743.

Full text

Abstract:

Selective portal vein embolization (PVE) before extended liver surgery is an accepted method to stimulate growth of the future liver remnant. Portal vein thrombosis (PVT) of the main stem and the non-targeted branches to the future liver remnant is a rare but major complication of PVE, requiring immediate revascularization. Without revascularization, curative liver surgery is not possible, resulting in a potentially life-threatening situation. We here present a new surgical technique to revascularize the portal vein after PVT by combining a surgical thrombectomy with catheter-based thrombolysi

APA, Harvard, Vancouver, ISO, and other styles

37

Onodera, Tomoya, Hisayoshi Fujiwara, Masaru Tanaka, et al. "-8-CORRELATION OF CORONARY ARTERIOGRAPHY DURING SELECTIVE INTRACORONARY THROMBOLYSIS WITH POSTMORTEM FINDINGS." Japanese Circulation Journal 50, no. 6 (1986): 461. http://dx.doi.org/10.1253/jcj.50.461_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Roy, Sumit, Frode Lærum, Frank Brosstad, Knut Kvernebo, and Kjell S. Sakariassen. "Selective Venous Thrombolysis with the Nipple-Balloon Catheter: Comparative Evaluation In Vivo." Journal of Vascular and Interventional Radiology 10, no. 6 (1999): 817–24. http://dx.doi.org/10.1016/s1051-0443(99)70121-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Cohen, José E., Samuel Moscovici, Michael Halpert, and Eyal Itshayek. "Selective thrombolysis performed through meningo-ophthalmic artery in central retinal artery occlusion." Journal of Clinical Neuroscience 19, no. 3 (2012): 462–64. http://dx.doi.org/10.1016/j.jocn.2011.06.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

van Leeuwen, Peter J. C. M., Arent B. Huisman, and Frits R. Hohmann. "Selective low-dose thrombolysis in patients with an axillary subclavian vein thrombosis." European Journal of Vascular Surgery 4, no. 5 (1990): 503–6. http://dx.doi.org/10.1016/s0950-821x(05)80792-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Wirostko, William J., Jose S. Pulido, and Lloyd E. Hendrix. "Selective thrombolysis of central retinal artery occlusion without long-term systemic heparinization." Surgical Neurology 50, no. 5 (1998): 408–10. http://dx.doi.org/10.1016/s0090-3019(97)00338-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Huang, Abbott B., Sidney Glanz, Man Hon, and Donald B. Price. "Renal Vein Thrombolysis with Selective Simultaneous Renal Artery and Renal Vein Infusions." Journal of Vascular and Interventional Radiology 6, no. 4 (1995): 581–84. http://dx.doi.org/10.1016/s1051-0443(95)71140-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Schmitz-Rode, Thomas, Markus Kilbinger, and Rolf W. Günther. "Simulated flow pattern in massive pulmonary embolism: Significance for selective intrapulmonary thrombolysis." CardioVascular and Interventional Radiology 21, no. 3 (1998): 199–204. http://dx.doi.org/10.1007/s002709900244.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Barnwell, Stanley L., Randall T. Higashida, Van V. Halbach, Christopher F. Dowd, and Grant B. Hieshima. "Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis." Neurosurgery 28, no. 1 (1991): 135–42. http://dx.doi.org/10.1227/00006123-199101000-00019.

Full text

Abstract:

Abstract Three patients, ages 51 to 71 years, sought treatment for symptomatic dural sinus thrombosis with occlusion and were treated by direct sinus perfusion with urokinase. All three patients had a dural arteriovenous fistula; one involved the inferior petrosal sinus and two involved the transverse sinus. Clinical findings included papilledema, diminished visual acuity, decreased mentation, and cranial nerve palsies. Diagnosis was made by cerebral arteriography and confirmed by sinus venography. All three patients were treated by a transjugular direct infusion of urokinase. In one patient,

APA, Harvard, Vancouver, ISO, and other styles

45

Heiss, Wolf-Dieter, and Olivier Zaro-Weber. "Extension of therapeutic window in ischemic stroke by selective mismatch imaging." International Journal of Stroke 14, no. 4 (2019): 351–58. http://dx.doi.org/10.1177/1747493019840936.

Full text

Abstract:

The concept of the ischemic penumbra was formulated on the basis of animal experiments showing functional impairment and electrophysiologic disturbances with decreasing flow to the brain below defined values (the threshold for function) and irreversible tissue damage with blood supply further decreased (the threshold for infarction). The perfusion range between these thresholds was termed the “penumbra,” and restitution of flow above the functional threshold was able to reverse the deficits without permanent damage. In further experiments, the dependency of the development of irreversible lesi

APA, Harvard, Vancouver, ISO, and other styles

46

Lokanathan, Ramesh, Anthony J. Salvian, Jerry C. Chen, Christopher Morris, David C. Taylor, and York N. Hsiang. "Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosis." Journal of Vascular Surgery 33, no. 4 (2001): 783–88. http://dx.doi.org/10.1067/mva.2001.112708.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tiefenbrunn, Alan J., and Burton E. Sobel. "Tissue-type plasminogen activator (t-PA): an agent with promise for selective thrombolysis." International Journal of Cardiology 7, no. 1 (1985): 82–86. http://dx.doi.org/10.1016/0167-5273(85)90181-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Roy, Sumit, Frode Lærum, and Frank Brosstad. "Quantitative evaluation of selective thrombolysis techniques: Influence of catheter characteristics and delivery parameters." Catheterization and Cardiovascular Diagnosis 43, no. 1 (1998): 111–19. http://dx.doi.org/10.1002/(sici)1097-0304(199801)43:1<111::aid-ccd32>3.0.co;2-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Duc, Hung Nguyen, Lam Truong Hoai, Long Nguyen Tuan, Minh Tran Duc, and Linh Duong Cong. "Selective thrombolysis trans-catheter for safe and effective subacute stent graft occlusion treatment." Radiology Case Reports 18, no. 10 (2023): 3549–52. http://dx.doi.org/10.1016/j.radcr.2023.07.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Roy, Sumit, Frank Brosstad, and Kjell S. Sakariassen. "Selective thrombolysis in acute deep vein thrombosis: Evaluation of adjuvant therapy in vivo." CardioVascular and Interventional Radiology 22, no. 5 (1999): 403–10. http://dx.doi.org/10.1007/s002709900415.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!